© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Descovy

Descoy Tablet held between tow fingers
FDA Approves Once-Daily Descovy for PrEP
Descoy Tablet and Descoy bottle
Descovy (tenofovir alafenamide + emtricitabine) 101
Chart of Approved and Experimental HIV Medications

More Than 1 in 3 New PrEP Prescriptions Were for Descovy in 2020

Plus, nearly a third of people already taking Truvada for PrEP switched to the new combination pill.
A sample from the “I Matter Therefor I PrEP” campaign in East Harlem.

“I Matter Therefore I PrEP” to Prevent HIV Among Latinos and Black Americans

An East Harlem HIV prevention campaign focuses on Black and Latino New Yorkers at higher risk.

Dolutegravir Plus TAF Associated With Steepest Weight Gain

However, all integrase inhibitors were associated with similar weight gain.

Oklahoma’s Plan to Prevent HIV and Get the Newly Diagnosed in Care

The Rapid Start and PrEP program in Oklahoma is part of the federal “Ending the HIV Epidemic” initiative.

Skip the Switch? HIV Integrase Inhibitors Have a High Barrier to Resistance

People whose viral load rebounds on Tivicay may not need to switch medications.

Could HIV Meds Reduce Eye Disease in People on PrEP or HIV Treatment?

Basic science may suggest it, but more studies still need to be done.
Megen Vo, MD, and Geoff Hart-Cooper, MD

PrEP Work

An HIV prevention roundup

“Ready, Set, PrEP” Offers HIV Prevention Meds by Mail

Enrollees in the national Ready, Set, PrEP program can now have their meds delivered via mail at no cost.

New Twist in the Gilead Patent Lawsuit Over Truvada and Descovy to Prevent HIV

The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP.

U.S. Government Updates Pregnancy and Perinatal HIV Guidelines

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

Why More Health Insurers Will Soon Cover PrEP for HIV Prevention

“All insurers failing to offer PrEP without cost sharing beginning in January 2021 are clearly not following the law.”
Megen Vo, MD and Geoff Hart-Cooper, MD, of the virtual PrEP program for youth at Stanford Children’s Health

Youth in California Can Virtually Access PrEP to Prevent HIV

A new PrEP telehealth system at Stanford Children’s Health offers HIV prevention to youth and adults 25 and younger.

Doctor-Patient Shared Decision-Making Can Help Guide PrEP Use Choices

At a recent conference, a leading infectious disease provider in New York City advocated this as a means of improving patient satisfaction.

For Women, Injectable Cabotegravir Is More Effective Than Truvada as PrEP

Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.

Study Sheds Light on Weight Gain After Switching to New Tenofovir

This may reflect loss of the weight-suppressing effect of the older version of the drug.

Does Truvada Offer Protection Against COVID-19?

Studies of the link between tenofovir use and coronavirus infection or COVID-19 outcomes have yielded mixed results.
Advertisement
Science News
Blog: Undetectable = Untransmittable